Author Response: The Role of IL-18 in the Treatment of AMD

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8237-8. doi: 10.1167/iovs.15-18714.

Authors

Sarah L Doyle¹, Francisco J López², Peter Humphries³, Peter Adamson⁴, Matthew Campbell³

Affiliations

¹ Department of Clinical Medicine School of Medicine, Trinity College Dublin, Dublin 2, Ireland;
² Allergan Incorporated, Irvine, California, United States;
³ Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland; and the.
⁴ UCL, ORBIT, Institute of Ophthalmology, London, United Kingdom.

PMID: 26720477
DOI: 10.1167/iovs.15-18714

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Endothelial Cells / pathology*
Female
Humans
Immunotherapy / methods*
Interleukin-18 / administration & dosage*
Macular Degeneration / drug therapy*
Retinal Neovascularization / drug therapy*

Substances

Interleukin-18